title: Braving a faceless new world? Conceptualizing trust in the pharmaceutical industry and its products.
abstract: Pharmaceutical products are commonly relied upon by professionals, and correspondingly patients, within a wide range of healthcare contexts. This dependence, combined with the inherent risk and uncertainty surrounding both medical practice and the drugs it harnesses, points towards the importance of trust in the pharmaceutical industry--a subject which has been much neglected by researchers. This article begins to address this deficiency by mapping out a conceptual framework which may form a useful basis for future research into this important topic. The often negative portrayal of the pharmaceutical industry in the public sphere belies a state of apparent confidence in its products. The role of prescribing professionals as 'mediators of trust' amid a faceless system of production and, alongside regulators, as bases of assurance in the quality of drugs goes some way towards explaining this contradiction. Recent policy moves towards fostering increased patient 'expertise' and responsibility for illness management, a widening of over-the-counter medication availability and a growing market of products (mainstream and illicit) via the Internet suggest this role of 'facework' in facilitating trust may be becoming more marginal. This heightened requirement for trusting amid the unfamiliar, and an apparent willingness to do so, underlines the need for further research into trust in the industry--both mainstream and underground--and its products. Within this discussion an agenda for furthering our understandings of the political-economy of the pharmaceutical industry becomes apparent, one which might be most effectively approached by way of a broader political-economy of hope and trust.
authors.affiliation: School of Social Policy, Sociology and Social Research, University of Kent, Canterbury, UK. p.r.brown@kent.ac.uk
authors.forename: Patrick
authors.initials: P
authors.lastname: Brown
authors.forename: Michael
authors.initials: M
authors.lastname: Calnan
mesh_terms: D026683:Advisory Committees; D004345:Drug Industry / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D020407:Internet; D004366:Nonprescription Drugs; D010358:Patient Participation; D011639:Public Opinion; D012106:Research; D035502:Trust
chemical_list: D004366:Nonprescription Drugs